NIR-Responsive Gold-Decorated Phase-Change Nanodroplets for Photothermal-Triggered Pulsatile Doxorubicin Release and Enhanced Combined Photothermal-Chemotherapy in Triple-Negative Breast Cancer.

Luyao Ma, Fulai Chen, Qinghao Xu, Jianwei Yu, Yang Liu, Lei Duan

Abstract read

In one paragraph

Article in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Programmable Organic APharmaceutics · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Luyao MaSchool of Biomedical Engineering and Informatics, Nanjing Medical University, Nanjing 211166, China.

Fulai ChenSchool of Biomedical Engineering and Informatics, Nanjing Medical University, Nanjing 211166, China.

Qinghao XuSchool of Biomedical Engineering and Informatics, Nanjing Medical University, Nanjing 211166, China.

Jianwei YuSchool of Biomedical Engineering and Informatics, Nanjing Medical University, Nanjing 211166, China.

Yang LiuSchool of Biomedical Engineering and Informatics, Nanjing Medical University, Nanjing 211166, China.

Lei DuanSchool of Biomedical Engineering and Informatics, Nanjing Medical University, Nanjing 211166, China.

Funding

Department of Finance of Jiangsu Province BK20230837National Natural Science Foundation of China 32401258

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

controlled drug releasephase-change nanodropletphotothermal therapytriple-negative breast cancer

Identifiers

PMID42514894

DOI10.3390/pharmaceutics18070816

PMCPMC13415136

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.